| __timestamp | Corcept Therapeutics Incorporated | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 5903000 |
| Thursday, January 1, 2015 | 1361000 | 2762000 |
| Friday, January 1, 2016 | 2058000 | 1114000 |
| Sunday, January 1, 2017 | 3554000 | 25573000 |
| Monday, January 1, 2018 | 5215000 | 6000000 |
| Tuesday, January 1, 2019 | 5504000 | 38845000 |
| Wednesday, January 1, 2020 | 5582000 | 50523000 |
| Friday, January 1, 2021 | 5281000 | 75463000 |
| Saturday, January 1, 2022 | 5385000 | 105767000 |
| Sunday, January 1, 2023 | 6481000 | 167512000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, understanding financial health is crucial. This analysis delves into the cost of revenue for Corcept Therapeutics Incorporated and Xenon Pharmaceuticals Inc. over the past decade. From 2014 to 2023, Corcept Therapeutics saw a steady increase in its cost of revenue, peaking at approximately $6.5 million in 2023, a growth of over 600% from 2014. Meanwhile, Xenon Pharmaceuticals experienced a dramatic rise, with costs surging from around $5.9 million in 2014 to a staggering $167.5 million in 2023, marking an increase of over 2,700%.
This data highlights the contrasting financial trajectories of these two companies. While both have expanded, Xenon's aggressive growth strategy is evident in its soaring costs. Investors and industry analysts can glean valuable insights into the operational strategies and market positioning of these biotech firms through such financial metrics.
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue: Key Insights for BeiGene, Ltd. and Corcept Therapeutics Incorporated
Exelixis, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated's Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue: Key Insights for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs ACADIA Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored